ProteoTech Selected to Present at Cavendish Global Health Impact Forum
5/2/2014 9:49:28 AM
ProteoTech, Inc., a therapeutic drug discovery development company targeting misfolded proteins and amyloid diseases, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 5-7, New York, NY. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by